glp-1 ckd Glucagon-like peptide-1 receptor agonists in diabetic kidney disease: A review of their kidney and heart protection Recommendations for SGLT2i versus GLP-1
Description
With applications expanding from diabetes and obesity into cardiovascular disease, longevity and wellness, the commercial opportunity continues to grow, intensifying the competition for strategic assets
Gribble FM
GLP-1R agonist therapy for diabetes: benefits andpotential risks
Always Pack a Sweatshirt Yes, even in the summer
